These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related]
4. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells. Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031 [TBL] [Abstract][Full Text] [Related]
5. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer. Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036 [TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage. Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105 [TBL] [Abstract][Full Text] [Related]
7. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth. Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358 [TBL] [Abstract][Full Text] [Related]
8. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation. Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895 [TBL] [Abstract][Full Text] [Related]
10. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development. Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648 [TBL] [Abstract][Full Text] [Related]
11. ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target. Erfani M; Zamani M; Hosseini SY; Mostafavi-Pour Z; Shafiee SM; Saeidnia M; Mokarram P Mol Biol Rep; 2021 Oct; 48(10):6749-6756. PubMed ID: 34424445 [TBL] [Abstract][Full Text] [Related]
12. Methylation of Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151 [TBL] [Abstract][Full Text] [Related]
13. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Arnold CN; Goel A; Boland CR Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer. Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467 [TBL] [Abstract][Full Text] [Related]
15. IGFBP3 gene promoter methylation analysis and its association with clinicopathological characteristics of colorectal carcinoma. Kumar A; Singh P; Pandey A; Gosipatala SB Mol Biol Rep; 2020 Sep; 47(9):6919-6927. PubMed ID: 32929656 [TBL] [Abstract][Full Text] [Related]
16. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53. Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734 [TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer. Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120 [TBL] [Abstract][Full Text] [Related]
18. Roles of ARID1A variations in colorectal cancer: a collaborative review. Zhao S; Wu W; Jiang Z; Tang F; Ding L; Xu W; Ruan L Mol Med; 2022 Apr; 28(1):42. PubMed ID: 35421925 [TBL] [Abstract][Full Text] [Related]
19. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer. Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage. Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]